Discovery of Pyridones As Oral AMPK Direct Activators
Citations Over TimeTop 24% of 2013 papers
Abstract
AMP-activated protein kinase (AMPK) is an evolutionarily conserved fuel-sensing enzyme that is activated in shortage of energy and suppressed in its surfeit. AMPK activation stimulates fatty acid oxidation, enhances insulin sensitivity, alleviates hyperglycemia and hyperlipidemia, and inhibits proinflammatory changes. Thus, AMPK is a well-received therapeutic target for type 2 diabetes and other metabolic disorders. Here, we will report the discovery of pyrrolopyridone derivatives as AMPK direct activators. We will illustrate the synthesis and structure-activity relationships of the series as well as some pharmacokinetic results. Some compounds exhibited encouraging oral exposure and were evaluated in a mouse diabetic model. Compound 17 showed oral activity at 30 mg/kg on blood glucose.
Related Papers
- → Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes(2008)250 cited
- → [Research progress of Adenosine 5'-monophosphate-activated protein kinase in the regulation of glycolipid metabolism].(2019)4 cited
- → Homogenous Fluorescent Assays for Characterizing Small-Molecule Activators of AMP-Activated Protein Kinase (AMPK)(2008)2 cited
- New findings in AMP-activated protein kinase(2014)
- 돌외 추출물로부터 순수 분리된 saponin 계열의 화합물인 Damulin B에 의한 AMP-activated protein kinase (AMPK)의 활성화 기작에 대한 연구(2011)